Global Pharma, Biotech & Diagnostics Co-promotion and Co-marketing Partnering Contracts Directory 2020
December 17, 2020 09:03 ET
|
Research and Markets
Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020" report has been added to...
2020 Next Generation Sequencing (NGS) Library Preparation Life Science Dashboard: Survey Responses from 411 Scientists Across North America and Europe
December 15, 2020 05:43 ET
|
Research and Markets
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "2020 Next Generation Sequencing (NGS) Library Preparation Life Science Dashboard Series 1 (NA & EMEA)" report has been added to...
National Laboratories Point to Sugars as a Key Factor in Ideal Feedstock for Biofuels
October 19, 2020 11:08 ET
|
National Renewable Energy Laboratory (NREL)
Golden, CO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- – Popular wisdom holds that tall, fast-growing trees are best for biomass, but new research by two U.S. Department of Energy National Laboratories...
SRI International awarded $4.3M from DARPA to create rapid response therapeutic manufacturing system
October 07, 2020 10:30 ET
|
SRI International
Menlo Park, California, Oct. 07, 2020 (GLOBE NEWSWIRE) -- MENLO PARK, Calif. - October 6, 2020 - SRI International has been awarded $4.3 million from the Defense Advanced Research Projects Agency...
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
September 06, 2019 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) announces the availability of a NetworkNewsAudio publication titled, “Innovative...
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsWire Publication Reporting on Momentous Advances in Drug-Delivery Innovation
September 05, 2019 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a...
TRANSWESTERN DEVELOPMENT COMPANY APPOINTED DEVELOPMENT MANAGER FOR TRANSFORMATIVE TMC3 CAMPUS IN TEXAS MEDICAL CENTER
May 01, 2019 11:58 ET
|
Transwestern Development Company
HOUSTON, May 01, 2019 (GLOBE NEWSWIRE) -- Transwestern Development Co. (TDC®) today announces it has been selected to provide development services for the transformational TMC3 Campus by the Texas...
CIT GAP Funds Invests in Tympanogen to Advance Modern-Day Medical Treatments for Ear, Nose and Throat
February 28, 2019 09:37 ET
|
Center for Innovative Technology
Herndon, VA, Feb. 28, 2019 (GLOBE NEWSWIRE) -- The Center for Innovative Technology (CIT) announced today that CIT GAP Funds has invested in Richmond, VA-based Tympanogen, Inc., a medical technology...
Uptick Newswire Hosts Pressure BioSciences, Inc. on the Stock Day Podcast to Discuss Their (1) Just Announced Collaboration With NutraFuels, Inc., (2) the Commercial Launch of Their BioPharmaceuticals Contract Services Business, and (3) the Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018
February 04, 2019 08:13 ET
|
Pressure BioSciences, Inc.
PHOENIX, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of...
Pressure BioSciences Inc. Discusses New Instrument Release, Entry into the Worldwide Food Science Area, and their Innovative Ultra Shear Technology Platform on Uptick Newswire’s Stock Day Podcast
October 01, 2018 08:30 ET
|
Pressure BioSciences, Inc.
PHOENIX, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Pressure BioSciences Inc. (OTCQB: PBIO) (the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments,...